Acute Treatment of Atrial Fibrillation and Flutter

This publication has 18 references indexed in Scilit:

• Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled study
  American Heart Journal, 1995
• Efficacy of class ia antiarrhythmic drugs in converting atrial fibrillation unassociated with organic heart disease and their relation to atrial electrophysiologic characteristics
  The American Journal of Cardiology, 1994
• Cerebral thromboembolization after cardioversion of atrial fibrillation in patients without transesophageal echocardiographic findings of left atrial thrombus
  American Heart Journal, 1993
• Management of atrial tachyarrhythmias in the critically ill: A comparison of intravenous procainamide and amiodarone
  Intensive Care Medicine, 1993
• Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide
  The American Journal of Cardiology, 1991
• Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter
  The American Journal of Cardiology, 1989
• Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm
  The American Journal of Cardiology, 1989
• Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias
  American Heart Journal, 1986
• Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: A multicenter double-blind clinical trial
  American Heart Journal, 1985
• Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion
  American Heart Journal, 1983